Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp block with bupivacaine for pain and PONV reduction after facelift surgery
PACTR202512764670297Phase 4Recruiting
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bupivacaine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Incidence and severity of postoperative nausea and vomiting. Started Dec 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202512764670297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512764670297.